AJMC Staff

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A statement about the acquisition promises that Navigating Cancer will operate independently with no differences in service regardless of a practice's status with a management service organization.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Roughly 7% of US women of reproductive age have attempted self-induced abortions after the overturning of Roe v Wade in 2022; the FDA announced that the cost to file a drug using clinical data will increase to about $4.3 million in 2025; the suicide rate among US children aged between 8 to 12 years has steadily risen during the past 15 years.

Smokers with diabetes on Ozempic are less likely to receive smoking cessation interventions; initiative incentivizes hospitals to eliminate medical debt for low- and middle-income patients; high costs prevent mental health treatment.

Efforts aim to protect health sector from rising threats; chronic anxiety nearly triples dementia risk; patients report overdoses up to 20 times the prescribed dosage of compounded semaglutide.

The ending of the 2023 film “Barbie,” where she sees a gynecologist, has increased online search interest in gynecology; yesterday marked 34 years of the Americans With Disabilities Act (ADA); Texas Attorney General Ken Paxton is suing the Biden administration over Title X, a federal contraception program that provides teens birth control without parental consent.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A federal appeals court ruled yesterday that a group of Republican-led states do not have legal standing to impose restrictions on the abortion pill mifepristone; the US infant mortality rate increased by 3% in 2022; a twice-yearly injection could prevent 100% of HIV infections.

Lawmakers cross-examined pharmacy benefit manager (PBM) representatives during a Congressional hearing; the proportion of hospital inpatients covered by private Medicare Advantage (MA) plans is rapidly increasing; public health officials are concerned after poliovirus was found in sewage samples from Gaza.

Efforts to regulate social media for youth face resistance; MK-1654 meets key goals in mid-to-late stage trial; active drug shortages remain above 300 for sixth consecutive quarter.

New rules aim to curb insurance brokers and protect consumers; data highlights surge in post-pandemic hospital-onset infections; President Biden’s decision to step down highlights Harris’ stance on health care reform and equity.

Rising COVID-19 cases are attributed to travel, heatwaves, and new variants; an analysis highlights challenges in states not expanding Medicaid; the FDA notes health risks despite marketing authorization for popular e-cigarettes.

Misleading ads are under scrutiny for their role in signing up consumers for Affordable Care Act (ACA) coverage without their permission; Sen Elizabeth Warren (D, Massachusetts) said there are enough votes in the Senate to suspend the filibuster to codify Roe v Wade in 2025 with a Democratic majority; women with endometriosis have about a fourfold risk of developing ovarian cancer.

Almost half of all Americans struggle to afford quality health care and prescription medications; the cyberattack on UnitedHealth Group's Change Healthcare unit will cost the company between $2.3 billion and $2.45 billion in 2024; CMS releases the final part 2 guidance for plan outreach and education for the Medicare Prescription Payment Plan.

Senate Democrats are meeting with Novo Nordisk executives to address the decision to stop selling a long-acting insulin in the country; research is attempting to prove the health benefits of new weight loss drugs beyond weight loss abilities in order to reimburse expensive medications; Vertex Pharmaceuticals is suing HHS over financial support of its gene-editing therapy.

Up to one-third of Americans have been affected by data stolen through the Change Healthcare cyberattack; research highlights potential cognitive and psychiatric benefits of semaglutide; over 40 Iowa hospitals have ended their labor and delivery services.

A small trial by investigators at the National Cancer Institute holds promise to bring personalized cell therapy into the solid tumor arena, after more than a decade of success in blood cancers.

Pfizer announced plans for a once-a-day weight-loss pill; toxic metals have been found in over a dozen popular tampon brands across the US; CMS proposed a new rules impacting telehealth in the Medicare physician fee schedule (PFS) for 2025.